Yahoo
LSE - Delayed Quote USD

Integrated Diagnostics Holdings plc (IDHC.L)

0.4511 +0.0011 (+0.24%)
As of 8:00:18 AM GMT. Market Open.
Chart Range Bar
Loading chart for IDHC.L
  • Previous Close 0.4500
  • Open 0.4511
  • Bid 0.4510 x --
  • Ask 0.4990 x --
  • Day's Range 0.4511 - 0.4511
  • 52 Week Range 0.4500 - 0.8350
  • Volume 5,848
  • Avg. Volume 588,495
  • Market Cap (intraday) 262.236M
  • Beta (5Y Monthly) 0.41
  • PE Ratio (TTM) 9.00
  • EPS (TTM) 0.0500
  • Earnings Date --
  • Forward Dividend & Yield 0.01 (1.89%)
  • Ex-Dividend Date May 28, 2026
  • 1y Target Est 0.80

Integrated Diagnostics Holdings plc, a consumer healthcare company, provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, such as positron emission tomography - computed tomography (PET-CT), MRI, computed tomography (CT), mammography, ultrasound, X-Ray, electromyography, electroencephalography, electroencephalogram, and electrocardiogram, as well as operates cath lab facilities. It operates in Egypt, Sudan, Nigeria, and the Kingdom of Saudi Arabia. The company was founded in 1979 and is based in Saint Helier, Jersey.

www.idhcorp.com

7,137

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .

YTD Return

IDHC.L
38.66%
FTSE 100 (^FTSE)
8.04%

1-Year Return

IDHC.L
18.76%
FTSE 100 (^FTSE)
9.94%

3-Year Return

IDHC.L
20.90%
FTSE 100 (^FTSE)
46.43%

5-Year Return

IDHC.L
56.19%
FTSE 100 (^FTSE)
48.25%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY23
Revenue 915.29M
Earnings --
Profit Margin 0.00%

Q1

FY22

Q2

FY22

Q3

FY22

Q1

FY23

0
200M
400M
600M
800M
1B
0.0%
5.0%
10.0%
15.0%
20.0%
25.0%

Analyst Insights

View More

Analyst Price Targets

0.76
0.80 Average
0.4511 Current
0.84 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    16.71%

  • Return on Assets (ttm)

    18.92%

  • Return on Equity (ttm)

    36.76%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    0.0500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    35.75%

  • Levered Free Cash Flow (ttm)

    1.09B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: